AAAAAA
Results:
1-20
|
Results: 20
Authors:
Cefai, D
Schwaninger, R
Balli, M
Brunner, T
Gimmi, CD
Citation: D. Cefai et al., Functional characterization of Fas ligand on tumor cells escaping active specific immunotherapy, CELL DEAT D, 8(7), 2001, pp. 687-695
Authors:
Brunner, T
Arnold, D
Wasem, C
Herren, S
Frutschi, C
Citation: T. Brunner et al., Regulation of cell death and survival in intestinal intraepithelial lymphocytes, CELL DEAT D, 8(7), 2001, pp. 706-714
Authors:
Grabenbauer, GG
Rodel, C
Brunner, T
Schulze-Mosgau, S
Strnad, V
Muller, RG
Iro, H
Sauer, R
Citation: Gg. Grabenbauer et al., Interstitial brachytherapy with Ir-192 low-dose-rate in the treatment of primary and recurrent cancer of the oral cavity and oropharynx - Review of 318 patients treated between 1985 and 1997, STRAH ONKOL, 177(7), 2001, pp. 338-344
Authors:
El-Sheik, M
Heverhagen, JT
Alfke, H
Froelich, JJ
Hornegger, J
Brunner, T
Klose, KJ
Wagner, HJ
Citation: M. El-sheik et al., Multiplanar reconstructions and three-dimensional imaging (computed rotational osteography) of complex fractures by using a C-arm system: Initial results, RADIOLOGY, 221(3), 2001, pp. 843-849
Authors:
Daniel, C
Duffield, J
Brunner, T
Steinmann-Niggli, K
Lods, N
Marti, HP
Citation: C. Daniel et al., Matrix metalloproteinase inhibitors cause cell cycle arrest and apoptosis in glomerular mesangial cells, J PHARM EXP, 297(1), 2001, pp. 57-68
Authors:
Wasem, C
Frutschi, C
Arnold, D
Vallan, C
Lin, T
Green, DR
Mueller, C
Brunner, T
Citation: C. Wasem et al., Accumulation and activation-induced release of preformed Fas (CD95) ligandduring the pathogenesis of experimental graft-versus-host disease, J IMMUNOL, 167(5), 2001, pp. 2936-2941
Authors:
Kasibhatla, S
Beere, HM
Brunner, T
Echeverri, F
Green, DR
Citation: S. Kasibhatla et al., A 'non-canonical' DNA-binding element mediates the response of the Fas-ligand promoter to c-Myc, CURR BIOL, 10(19), 2000, pp. 1205-1208
Authors:
Kastl, S
Brunner, T
Herrmann, O
Riepl, M
Fietkau, R
Grabenbauer, G
Sauer, R
Hohenberger, W
Klein, P
Citation: S. Kastl et al., Neoadjuvant radio-chemotherapy in advanced primarily non-resectable carcinomas of the pancreas, EUR J SUR O, 26(6), 2000, pp. 578-582
Authors:
Wiesent, K
Barth, K
Navab, N
Durlak, P
Brunner, T
Schuetz, O
Seissler, W
Citation: K. Wiesent et al., Enhanced 3-D-reconstruction algorithm for C-arm systems suitable for interventional procedures, IEEE MED IM, 19(5), 2000, pp. 391-403
Authors:
Pinkoski, MJ
Brunner, T
Green, DR
Lin, T
Citation: Mj. Pinkoski et al., Fas and Fas ligand in gut and liver, AM J P-GAST, 278(3), 2000, pp. G354-G366
Authors:
Corazza, N
Muller, S
Brunner, T
Kagi, D
Mueller, C
Citation: N. Corazza et al., Differential contribution of Fas- and perforin-mediated mechanisms to the cell-mediated cytotoxic activity of naive and in vivo-primed intestinal intraepithelial lymphocytes, J IMMUNOL, 164(1), 2000, pp. 398-403
Authors:
Brunner, T
Kasibhatla, S
Pinkoski, MJ
Frutschi, C
Yoo, NJ
Echeverri, F
Mahboubi, A
Green, DR
Citation: T. Brunner et al., Expression of Fas ligand in activated T cells is regulated by c-Myc, J BIOL CHEM, 275(13), 2000, pp. 9767-9772
Authors:
Askew, DJ
Kuscuoglu, U
Brunner, T
Green, DR
Miesfeld, RL
Citation: Dj. Askew et al., Characterization of Apt- cell lines exhibiting cross-resistance to glucocorticoid- and Fas-mediated apoptosis, CELL DEAT D, 6(8), 1999, pp. 796-804
Authors:
Brunner, T
Mueller, C
Citation: T. Brunner et C. Mueller, Is autoimmunity coming to a Fas(t) end?, NAT MED, 5(1), 1999, pp. 19-20
Authors:
Brunner, T
Mueller, C
Citation: T. Brunner et C. Mueller, Cytotoxic T cells: Double-barreled shot guns, NAT MED, 5(1), 1999, pp. 20-20
Authors:
Brunner, T
Citation: T. Brunner, Multiple therapy for resectable pancreatic carcinoma, STRAH ONKOL, 175(8), 1999, pp. 413-414
Authors:
Baum, U
Lell, M
Nomayr, A
Wolf, H
Brunner, T
Greess, H
Buatz, W
Citation: U. Baum et al., Multislice spiral CT for the diagnostics of pancreatic tumors, RADIOLOGE, 39(11), 1999, pp. 958-964
Authors:
Mueller, C
Corazza, N
Trachsel-Loseth, S
Eugster, HP
Buhler-Jungo, M
Brunner, T
Imboden, MA
Citation: C. Mueller et al., Noncleavable transmembrane mouse tumor necrosis factor-alpha (TNF alpha) mediates effects distinct from those of wild-type TNF alpha in vitro and in vivo, J BIOL CHEM, 274(53), 1999, pp. 38112-38118
Authors:
Bonfoco, E
Stuart, PM
Brunner, T
Lin, T
Griffith, TS
Gao, Y
Nakajima, H
Henkart, PA
Ferguson, TA
Green, DR
Citation: E. Bonfoco et al., Inducible nonlymphoid expression of Fas ligand is responsible for superantigen-induced peripheral deletion of T cells, IMMUNITY, 9(5), 1998, pp. 711-720
Authors:
Schriber, JJ
Brunner, T
Citation: Jj. Schriber et T. Brunner, Discrete-event simulation software works, HANDBOOK OF SIMULATION, 1998, pp. 765-811
Risultati:
1-20
|